Friday, July 31, 2026

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

North Korea’s Ri Il-hwan Returns: What is the Reason of His Long Disappearance?

Ri Il-hwan reappears after a year, raising speculation about his absence. Analysts discuss potential disciplinary actions or health issues.

8 Countries Nationals “North Korea Nuclear Is Threat Factor, South-North Unification Is Difficult”

A survey shows global support for Korean reunification but doubts its feasibility, with varying perceptions across different countries.

Tag: S2 Entertainment

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.